REQUEST A DEMO
Total
USD $0.00
Search more companies

Bome Trivitron Sanayi Urunleri Dis Ticaret A.S. (Turkiye)

Main Activities: In-Vitro Diagnostic Substance Manufacturing
Full name: Bome Trivitron Sanayi Urunleri Dis Ticaret Anonim Sirketi Profile Updated: December 12, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English Download a sample report

Bome Trivitron Sanayi Urunleri Dis Ticaret A.S. is based in Turkiye. The head office is in Ankara. The company operates in the In-Vitro Diagnostic Substance Manufacturing sector. Bome Trivitron Sanayi Urunleri Dis Ticaret A.S. was incorporated on May 29, 1989. It currently has a total number of 105 (2023) employees. From the latest financial highlights, Bome Trivitron Sanayi Urunleri Dis Ticaret A.S. reported a net sales revenue increase of 19.54% in 2020. Over the same period, its total assets grew by 40.85%. The net profit margin of Bome Trivitron Sanayi Urunleri Dis Ticaret A.S. increased by 4.34% in 2020.

Headquarters
No:1 Ostim Osb Mahallesi 1250 Caddesi Yenimahalle
Ankara; Central Anatolia; Postal Code: 06374

Contact Details: Purchase the Bome Trivitron Sanayi Urunleri Dis Ticaret A.S. report to view the information.

Website: http://www.bome.com.tr

Basic Information
Total Employees:
Purchase the Bome Trivitron Sanayi Urunleri Dis Ticaret A.S. report to view the information.
Outstanding Shares:
Purchase the Bome Trivitron Sanayi Urunleri Dis Ticaret A.S. report to view the information.
Incorporation Date:
May 29, 1989
Key Executives
Purchase this report to view the information.
Vice Chariman
Company Performance
Financial values in the chart are available after Bome Trivitron Sanayi Urunleri Dis Ticaret A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
19.54%
Total operating revenue
19.54%
Operating profit (EBIT)
63.81%
Net Profit (Loss) for the Period
68.59%
Total assets
40.85%
Total equity
25.18%
Operating Profit Margin (ROS)
4.47%
Net Profit Margin
4.34%
Return on Equity (ROE)
7.67%
Debt to Equity Ratio
7.73%
Quick Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?